BUPLANT
Dead / Abandoned — Abandoned — no statement of use filed (as of 09 Dec 2019)
What this means for you
This application is over — abandoned 09 Dec 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87009766
- Mark type
- Stylized text
- Filed
- 21 Apr 2016
- Published for opposition
- 13 Sept 2016
- Abandoned
- 09 Dec 2019
- Attorney of record
- Jennifer Lee Taylor
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction and pain management; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases
Owner
- Titan Pharmaceuticals, Inc., South San Francisco, CA, US
- Titan Pharmaceuticals, Inc., South San Francisco, CA, US
Prosecution history
- 09 Dec 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 09 Dec 2019 — ABANDONMENT - NO USE STATEMENT FILED
- 04 May 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 May 2019 — SOU EXTENSION 5 GRANTED
- 30 Apr 2019 — SOU EXTENSION 5 FILED
- 03 May 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Apr 2019 — SOU TEAS EXTENSION RECEIVED
- 30 Oct 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Oct 2018 — SOU EXTENSION 4 GRANTED
- 26 Oct 2018 — SOU EXTENSION 4 FILED
- 26 Oct 2018 — SOU TEAS EXTENSION RECEIVED
- 02 May 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Apr 2018 — SOU EXTENSION 3 GRANTED
- 30 Apr 2018 — SOU EXTENSION 3 FILED
- 30 Apr 2018 — SOU TEAS EXTENSION RECEIVED